These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 9198047

  • 21. Red cell ferritin, a marker of iron deficiency in hemodialysis patients.
    Bhandari S, Owda AK, Kendall RG, Moran N, Norfolk DR, Brownjohn AM, Turney JH.
    Ren Fail; 1997 Nov; 19(6):771-80. PubMed ID: 9415934
    [Abstract] [Full Text] [Related]

  • 22. Percentage hypochromic red cells and the response to intravenous iron therapy in anaemic haemodialysis patients.
    Jones CH, Richardson D, Ayers S, Newstead CG, Will EJ, Davison AM.
    Nephrol Dial Transplant; 1998 Nov; 13(11):2873-6. PubMed ID: 9829493
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Evaluation of reticulocyte hemoglobin content, percentage of hypochromic red blood cells, and ratio of serum transferrin receptor level/serum iron level as markers of iron-deficiency erythropoiesis in patients undergoing hemodialysis].
    Hasegawa M, Kawamura N, Koide S, Murase M, Asano S, Toba T, Kushimoto H, Murakami K, Tomita M, Hasegawa H, Shikano M, Mizuno M, Funahashi N, Kawashima S, Sugiyama S.
    Nihon Jinzo Gakkai Shi; 2002 Nov; 44(5):453-63. PubMed ID: 12216478
    [Abstract] [Full Text] [Related]

  • 30. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients.
    Sitter T, Bergner A, Schiffl H.
    Nephrol Dial Transplant; 2000 Aug; 15(8):1207-11. PubMed ID: 10910446
    [Abstract] [Full Text] [Related]

  • 31. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.
    Tarng DC, Huang TP, Chen TW, Yang WC.
    Kidney Int Suppl; 1999 Mar; 69():S107-18. PubMed ID: 10084294
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Anemia and carnitine supplementation in hemodialyzed patients.
    Kletzmayr J, Mayer G, Legenstein E, Heinz-Peer G, Leitha T, Hörl WH, Kovarik J.
    Kidney Int Suppl; 1999 Mar; 69():S93-106. PubMed ID: 10084293
    [Abstract] [Full Text] [Related]

  • 35. How to get the best out of r-HuEPO.
    Hörl WH.
    Nephrol Dial Transplant; 1995 Mar; 10 Suppl 2():92-5. PubMed ID: 7644113
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity.
    Bader D, Blondheim O, Jonas R, Admoni O, Abend-Winger M, Reich D, Lanir A, Tamir A, Eldar I, Attias D.
    Acta Paediatr; 1996 Apr; 85(4):496-501. PubMed ID: 8740313
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.